256 related articles for article (PubMed ID: 1581912)
41. Inherited susceptibility to breast cancer.
Easton D; Ford D; Peto J
Cancer Surv; 1993; 18():95-113. PubMed ID: 8013003
[TBL] [Abstract][Full Text] [Related]
42. Germline mutations of the p53 tumor-suppressor gene in cancer-prone families: a review.
Soussi T; Leblanc T; Baruchel A; Schaison G
Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):33-6. PubMed ID: 8511038
[TBL] [Abstract][Full Text] [Related]
43. Screening for germ line TP53 mutations in breast cancer patients.
Børresen AL; Andersen TI; Garber J; Barbier-Piraux N; Thorlacius S; Eyfjörd J; Ottestad L; Smith-Sørensen B; Hovig E; Malkin D
Cancer Res; 1992 Jun; 52(11):3234-6. PubMed ID: 1591732
[TBL] [Abstract][Full Text] [Related]
44. TP53 mutation and haplotype analysis of two large African American families.
Hung J; Mims B; Lozano G; Strong L; Harvey C; Chen TT; Stastny V; Tomlinson G
Hum Mutat; 1999; 14(3):216-21. PubMed ID: 10477429
[TBL] [Abstract][Full Text] [Related]
45. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
46. G:C > A:T mutations and potential epigenetic regulation of p53 in breast cancer.
Kouidou S; Malousi A; Kyventidis A; Fragou A; Maglaveras N
Breast Cancer Res Treat; 2007 Dec; 106(3):351-60. PubMed ID: 17505880
[TBL] [Abstract][Full Text] [Related]
47. BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area.
Eachkoti R; Hussain I; Afroze D; Aejazaziz S; Jan M; Shah ZA; Das BC; Siddiqi MA
Cancer Lett; 2007 Apr; 248(2):308-20. PubMed ID: 16996204
[TBL] [Abstract][Full Text] [Related]
48. [Li-Fraumeni syndrome].
Tokunaga A; Onda M; Matsukura N; Kato S
Nihon Rinsho; 1995 Nov; 53(11):2797-802. PubMed ID: 8538047
[TBL] [Abstract][Full Text] [Related]
49. [Li-Fraumeni syndrome].
Tsunematsu Y
Nihon Rinsho; 2000 Jul; 58(7):1442-7. PubMed ID: 10921321
[TBL] [Abstract][Full Text] [Related]
50. [Li-Fraumeni syndrome and the p53 gene].
Thoresen SO
Tidsskr Nor Laegeforen; 1992 Mar; 112(7):887-9. PubMed ID: 1557756
[TBL] [Abstract][Full Text] [Related]
51. Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome.
Lee SB; Kim SH; Bell DW; Wahrer DC; Schiripo TA; Jorczak MM; Sgroi DC; Garber JE; Li FP; Nichols KE; Varley JM; Godwin AK; Shannon KM; Harlow E; Haber DA
Cancer Res; 2001 Nov; 61(22):8062-7. PubMed ID: 11719428
[TBL] [Abstract][Full Text] [Related]
52. Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.
Frebourg T; Kassel J; Lam KT; Gryka MA; Barbier N; Andersen TI; Børresen AL; Friend SH
Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6413-7. PubMed ID: 1631137
[TBL] [Abstract][Full Text] [Related]
53. [Familial breast cancer].
Fukutomi T; Inoue R; Ushijima T; Toyoda M
Nihon Rinsho; 1995 Nov; 53(11):2764-8. PubMed ID: 8538041
[TBL] [Abstract][Full Text] [Related]
54. Absence of p53 germ-line mutations in bilateral breast cancer patients.
Lidereau R; Soussi T
Hum Genet; 1992 May; 89(2):250-2. PubMed ID: 1587536
[TBL] [Abstract][Full Text] [Related]
55. The first documentation of Li-Fraumeni syndrome in Korea.
Bang YJ; Kang SH; Kim TY; Jung CW; Oh SM; Choe KJ; Kim NK
J Korean Med Sci; 1995 Jun; 10(3):205-10. PubMed ID: 8527048
[TBL] [Abstract][Full Text] [Related]
56. Genetic mapping of a third Li-Fraumeni syndrome predisposition locus to human chromosome 1q23.
Bachinski LL; Olufemi SE; Zhou X; Wu CC; Yip L; Shete S; Lozano G; Amos CI; Strong LC; Krahe R
Cancer Res; 2005 Jan; 65(2):427-31. PubMed ID: 15695383
[TBL] [Abstract][Full Text] [Related]
57. Spectrum of p53 tumor suppressor gene mutations and breast cancer survival.
Lai H; Ma F; Trapido E; Meng L; Lai S
Breast Cancer Res Treat; 2004 Jan; 83(1):57-66. PubMed ID: 14997055
[TBL] [Abstract][Full Text] [Related]
58. p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition.
Vahteristo P; Tamminen A; Karvinen P; Eerola H; Eklund C; Aaltonen LA; Blomqvist C; Aittomäki K; Nevanlinna H
Cancer Res; 2001 Aug; 61(15):5718-22. PubMed ID: 11479205
[TBL] [Abstract][Full Text] [Related]
59. [Cancer family syndrome in lung cancer--Li-Fraumeni syndrome in lung cancer].
Tomita M; Tagawa Y; Tsuji T; Tsuji H; Ayabe H
Nihon Rinsho; 1995 Nov; 53(11):2716-21. PubMed ID: 8538032
[TBL] [Abstract][Full Text] [Related]
60. A functional screen for germ line p53 mutations based on transcriptional activation.
Frebourg T; Barbier N; Kassel J; Ng YS; Romero P; Friend SH
Cancer Res; 1992 Dec; 52(24):6976-8. PubMed ID: 1458490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
